Esperion Therapeutics, Inc.

ESPR

Held by 0 specialist biotech funds

Share

Signal Score

0.0/10

See how each signal contributes— fund overlap, insider activity, catalyst timing, short interest (free trial)

ESPR is not currently held by any of our tracked specialist biotech funds.

Fund positions update quarterly with new 13F filings. Explore fund convergence to see which tickers multiple funds hold.

No catalysts tracked.

SC 13G/ADeep Track Capital0.0%Feb 14, 2024

SC 13GDeep Track Capital10.0%Dec 9, 2021

SC 13G/ABoxer Capital3.6%Feb 14, 2020

SC 13G/ABoxer Capital4.8%Feb 14, 2019

SC 13G/ABoxer Capital5.1%Oct 30, 2018

SC 13GBoxer Capital5.1%May 11, 2018

SC 13G/ABoxer Capital3.1%Feb 14, 2018

SC 13GBoxer Capital5.3%Mar 23, 2017

No position data available.

No insider purchases or sales detected in the past 90 days.

Track specialist biotech funds, insider signals, and AI analysis

Get free weekly alerts on fund moves and catalysts: